Baxter International | BAX - هزینه بهره بدهی

قیمت سهام
17.19
تغییر روزانه
-0.21 -1.21%
ماهیانه
-17.12%
سالیانه
-50.67%
Q1 پیش بینی
16.87




هزینه بهره بدهی تغییر دادن تاریخ
Abbott USD 42M 2M 2025-12
AngioDynamics USD 100K 134K 2025-02
Artivion USD 5.53M 589K 2025-12
AtriCure USD 1.33M 17K 2025-09
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Fresenius EUR 81M 5M 2025-09
Globus Medical USD 17K 5.1B 2025-12
Halozyme Therapeutics USD 4.91M 615K 2025-12
ICU Medical USD 20.64M 21.39M 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 19.35B 811.4M 2025-09
J&J USD 18M 290M 2025-09
Laboratory Of America USD 55M 1000K 2025-12
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Smith & Nephew USD 69M 1000K 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Terumo JPY 463M 445M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12